This showed that, at least in vitro and on ex vivo primary MM cells, the level of HLA-E on the MM cells was not sufficient to trigger potent inhibitory signaling via CD94-NKG2A (64). The gene discussed is HLA-E; the disease is Miyoshi myopathy.